Developing a Standard Set of Patient-Centred Outcomes for inflammatory Bowel Disease-an international, cross-disciplinary consensus

Journal of Crohn's and Colitis

Volumn 12, Issue 4, 2018, Pages 408-418

  Kim, Andrew H ^a   Roberts, Charlotte ^b   Feagan, Brian G ^c   Banerjee, Rupa ^d   Bemelman, Willem ^e   Bodger, Keith ^f,g   Derieppe, Marc ^h   Dignass, Axel ⁱ   Driscoll, Richard ^j   Fitzpatrick, Ray ^k   Gaarentstroom Lunt, Janette ^l   Higgins, Peter D ^m   Kotze, Paulo Gustavo ⁿ   Meissner, Jillian ^o   O'Connor, Marian ^p   Ran, Zhi Hua ^q   Siegel, Corey A ^r   Terry, Helen ^s   van Deen, Welmoed K ^t,u   van der Woude, C Janneke ^v   Weaver, Alandra ^o   Yang, Suk Kyun ^w   Sands, Bruce E ^x   Vermeire, Séverine ^y   Travis, Simon P L ^a   more..

^a JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^b International Consortium on Health Outcomes Measurement   (United Kingdom)

^c UNIVERSITY OF WESTERN ONTARIO   (Canada)

^d ASIAN INSTITUTE OF GASTROENTEROLOGY   (India)

^e ACADEMIC MEDICAL CENTER   (Netherlands)

^f UNIVERSITY OF LIVERPOOL   (United Kingdom)

^g UNIVERSITY HOSPITAL AINTREE   (United Kingdom)

^h Association François Aupetit   (France)

ⁱ GOETHE UNIVERSITY   (Germany)

^j Health Quality Improvement Partnership   (United Kingdom)

^k UNIVERSITY OF OXFORD   (United Kingdom)

^l UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^m UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

ⁿ PONTIFICAL CATHOLIC UNIVERSITY OF PARANÁ   (Brazil)

^o Crohn's and Colitis Foundation of America   (United States)

^p EALING HOSPITAL NHS TRUST   (United Kingdom)

^q SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^r DARTMOUTH HITCHCOCK MEDICAL CENTER   (United States)

^s Crohn's and Colitis UK Leeds and District Group   (United Kingdom)

^t UNIVERSITY OF CALIFORNIA   (United States)

^u UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^v ERASMUS MEDICAL CENTER   (Netherlands)

^w University of Ulsan College of Medicine   (South Korea)

^x MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^y UNIVERSITY HOSPITALS LEUVEN   (Belgium)

more..

Author keywords

Inflammatory bowel disease; Patient reported outcomes; Quality improvement

Indexed keywords

ADOLESCENT; ANEMIA; ARTICLE; CLINICAL ARTICLE; COLORECTAL CANCER; CONSENSUS DEVELOPMENT; DISEASE CONTROL; EMERGENCY WARD; FEMALE; FISTULA; GASTROENTEROLOGIST; HEALTH CARE UTILIZATION; HUMAN; INFLAMMATORY BOWEL DISEASE; MALE; NURSE SPECIALIST; NUTRITIONAL STATUS; OUTCOME ASSESSMENT; PRIORITY JOURNAL; QUALITY OF LIFE; REMISSION; RISK ASSESSMENT; STANDARD; SURGEON; SURVIVAL; TELECONFERENCE; ADULT; AGED; COLORECTAL TUMOR; COMPLICATION; CONSENSUS; DELPHI STUDY; DISEASE EXACERBATION; HEALTH CARE PLANNING; HOSPITAL ADMISSION; HOSPITAL EMERGENCY SERVICE; INTERDISCIPLINARY COMMUNICATION; INTERNATIONAL COOPERATION; INTESTINE FISTULA; MIDDLE AGED; PATIENT-REPORTED OUTCOME; SURVIVAL RATE; UTILIZATION; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANEMIA; COLORECTAL NEOPLASMS; CONSENSUS; DELPHI TECHNIQUE; DISEASE PROGRESSION; EMERGENCY SERVICE, HOSPITAL; FEMALE; HEALTH RESOURCES; HUMANS; INFLAMMATORY BOWEL DISEASES; INTERDISCIPLINARY COMMUNICATION; INTERNATIONALITY; INTESTINAL FISTULA; MALE; MIDDLE AGED; NUTRITIONAL STATUS; PATIENT ADMISSION; PATIENT OUTCOME ASSESSMENT; PATIENT REPORTED OUTCOME MEASURES; QUALITY OF LIFE; SURVIVAL RATE; YOUNG ADULT;

EID: 85051405736     PISSN: 18739946     EISSN: 18764479     Source Type: Journal    
DOI: 10.1093/ecco-jcc/jjx161     Document Type: Article

References (70)

1. Larsson S, Lawyer P, Garellick G, Lindahl B, Lundström M. Use of 13 disease registries in 5 countries demonstrates the potential to use outcome data to improve health care's value. Health Aff2012;31:220-7
2. Porter ME. Value-based health care delivery. Ann Surg 2008;248:503-9
3. Porter ME. A strategy for health care reform-toward a value-based system. N Engl J Med 2009;361:109-12
4. Porter ME, Teisberg EO. Redefining competition in health care. Harv Bus Rev 2004;82:64-76, 136
5. Porter ME. What is value in health care? N Engl J Med 2010;363:2477-81
6. Porter ME, Teisberg EO. How physicians can change the future of health care. JAMA 2007;297:1103-11
7. Porter ME, Larsson S, Lee TH. Standardizing patient outcomes measurement. N Engl J Med 2016;374:504-6
8. Muka T, Imo D, Jaspers L, et al. The global impact of non-communicable diseases on healthcare spending and national income: a systematic review. Eur J Epidemiol 2015;30:251-77
9. Mahmud I, Kelley T, Stowell C, et al. A proposed minimum standard set of outcome measures for cataract surgery. JAMA Ophthalmol 2015;133:1247-52
10. Burisch J, Jess T, Martinato M, Lakatos PL; ECCO-EpiCom. The burden of inflammatory bowel disease in Europe. J Crohns Colitis 2013;7:322-37
11. Huppertz-Hauss G, Lie Høivik M, Jelsness-Jørgensen LP, et al. Health-related quality of life in patients with inflammatory bowel disease 20 years after diagnosis: results from the IBSEN study. Inflamm Bowel Dis 2016;22:1679-87
12. Kaplan GG. The global burden of IBD: from 2015 to 2025. Nat Rev Gastroenterol Hepatol 2015;12:720-7
13. Nurmi E, Haapamäki J, Paavilainen E, Rantanen A, Hillilä M, Arkkila P. The burden of inflammatory bowel disease on health care utilization and quality of life. Scand J Gastroenterol 2013;48:51-7
14. Bouguen G, Peyrin-Biroulet L. Surgery for adult Crohn's disease: what is the actual risk? Gut 2011;60:1178-81
15. Hancock L, Mortensen NJ. How often do IBD patients require resection of their intestine? Inflamm Bowel Dis 2008;14 (Suppl 2):S68-9
16. Kappelman MD, Moore KR, Allen JK, Cook SF. Recent trends in the prevalence of Crohn's disease and ulcerative colitis in a commercially insured US population. Dig Dis Sci 2013;58:519-25
17. Kappelman MD, Porter CQ, Galanko JA, et al. Utilization of healthcare resources by U.S. children and adults with inflammatory bowel disease. Inflamm Bowel Dis 2011;17:62-8
18. Loftus EV Jr. Clinical epidemiology of inflammatory bowel disease: incidence, prevalence, and environmental influences. Gastroenterology 2004;126:1504-17
19. Molodecky NA, Soon IS, Rabi DM, et al. Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. Gastroenterology 2012;142:46-54.e42; quiz e30
20. Ng SC, Tang W, Ching JY, et al. Incidence and phenotype of inflammatory bowel disease based on results from the Asia-Pacific Crohn's and Colitis Epidemiology study. Gastroenterology 2013;145:158-65 e2
21. Siegel CA, Allen JI, Melmed GY. Translating improved quality of care into an improved quality of life for patients with inflammatory bowel disease. Clin Gastroenterol Hepatol 2013;11:908-12
22. Melmed GY, Siegel CA, Spiegel BM, et al. Quality indicators for inflammatory bowel disease: development of process and outcome measures. Inflamm Bowel Dis 2013;19:662-8
23. The IBD Standards Group. Standards for the Healthcare of People who have Inflammatory Bowel Disease (IBD)-IBD Standards 2013 Update. htttp://ibdstandards.org.uk. Accessed August 8, 2016
24. Crandall WV, Margolis PA, Kappelman MD, et al.; ImproveCareNow Collaborative. Improved outcomes in a quality improvement collaborative for pediatric inflammatory bowel disease. Pediatrics 2012;129:e1030-41
25. Crandall WV, Boyle BM, Colletti RB, Margolis PA, Kappelman MD. Development of process and outcome measures for improvement: lessons learned in a quality improvement collaborative for pediatric inflammatory bowel disease. Inflamm Bowel Dis 2011;17:2184-91
26. Crandall W, Kappelman MD, Colletti RB, et al. ImproveCareNow: the development of a pediatric inflammatory bowel disease improvement network. Inflamm Bowel Dis 2011;17:450-7
27. Nelson EC, Dixon-Woods M, Batalden PB, et al. Patient focused registries can improve health, care, and science. BMJ 2016;354:i3319
28. The COMET (Core Outcome Measures in Effectiveness Trials) Initiative. www.comet-initiative.org. Accessed September 23, 2016
29. ICHOM-International Consortium for Health Outcomes Measurement. www.ichom.org. Accessed July 9, 2016
30. de Roos P, Bloem BR, Kelley TA, et al. A consensus set of outcomes for Parkinson's disease from the international consortium for health outcomes measurement. J Parkinsons Dis 2017;7:533-43
31. Zerillo JA, Schouwenburg MG, van Bommel ACM, et al.; Colorectal Cancer Working Group of the International Consortium for Health Outcomes Measurement (ICHOM). An International collaborative standardizing a comprehensive patient-centered outcomes measurement set for colorectal cancer. JAMA Oncol 2017;3:686-94
32. Ong WL, Schouwenburg MG, van Bommel ACM, et al. A standard set of value-based patient-centered outcomes for breast cancer: The international consortium for health outcomes measurement (ICHOM) initiative. JAMA Oncol 2017;3:677-85
33. Mak KS, van Bommel AC, Stowell C, et al.; Lung Cancer Working Group of ICHOM. Defining a standard set of patient-centred outcomes for lung cancer. Eur Respir J 2016;48:852-60
34. McNamara RL, Spatz ES, Kelley TA, et al. Standardized outcome measurement for patients with coronary artery disease: consensus from the International Consortium for Health Outcomes Measurement (ICHOM). J Am Heart Assoc 2015;4:e001767
35. Morgans AK, van Bommel AC, Stowell C, et al.; Advanced Prostate Cancer Working Group of the International Consortium for Health Outcomes Measurement. Development of a standardized set of patient-centered outcomes for advanced prostate cancer: an international effort for a unified approach. Eur Urol 2015;68:891-8
36. Reeve BB, Wyrwich KW, Wu AW, et al. ISOQOL recommends minimum standards for patient-reported outcome measures used in patientcentered outcomes and comparative effectiveness research. Qual Life Res 2013;22:1889-905
37. Fitzpatrick R, Davey C, Buxton MJ, Jones DR. Evaluating patientbased outcome measures for use in clinical trials. Health Technol Assess 1998;2:i-iv, 1-74
38. Murphy MK, Black NA, Lamping DL, et al. Consensus development methods, and their use in clinical guideline development. Health Technol Assess 1998;2:i-iv, 1-88
39. Krueger RA. Designing and Conducting Focus Group Interviews, 2002. http://www.eiu.edu/ihec/Krueger-FocusGroupInterviews.pdf. Accessed December 14, 2015
40. Joyce JC, Waljee AK, Khan T, et al. Identification of symptom domains in ulcerative colitis that occur frequently during flares and are responsive to changes in disease activity. Health Qual Life Outcomes 2008;6:69
41. Waljee AK, Joyce JC, Wren PA, Khan TM, Higgins PD. Patient reported symptoms during an ulcerative colitis flare: a Qualitative Focus Group Study. Eur J Gastroenterol Hepatol 2009;21:558-64
42. Bodger K, Ormerod C, Shackcloth D, Harrison M; IBD Control Collaborative. Development and validation of a rapid, generic measure of disease control from the patient's perspective: the IBD-control questionnaire. Gut 2014;63:1092-102
43. Silverberg MS, Satsangi J, Ahmad T, et al. Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a Working Party of the 2005 Montreal World Congress of Gastroenterology. Can J Gastroenterol 2005;19 (Suppl A):5A-36A
44. Bennett AL, Moore D, Bampton PA, Bryant RV, Andrews JM. Outcomes and patients' perspectives of transition from paediatric to adult care in inflammatory bowel disease. World J Gastroenterol 2016;22:2611-20
45. Leung Y, Heyman MB, Mahadevan U. Transitioning the adolescent inflammatory bowel disease patient: guidelines for the adult and pediatric gastroenterologist. Inflamm Bowel Dis 2011;17:2169-73
46. Baldassano R, Ferry G, Griffiths A, Mack D, Markowitz J, Winter H. Transition of the patient with inflammatory bowel disease from pediatric to adult care: recommendations of the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition. J Pediatr Gastroenterol Nutr 2002;34:245-8
47. Clara I, Lix LM, Walker JR, et al. The Manitoba IBD Index: evidence for a new and simple indicator of IBD activity. Am J Gastroenterol 2009;104:1754-63
48. Guyatt G, Mitchell A, Irvine EJ, et al. A new measure of health status for clinical trials in inflammatory bowel disease. Gastroenterology 1989;96:804-10
49. Jess T, Simonsen J, Jørgensen KT, Pedersen BV, Nielsen NM, Frisch M. Decreasing risk of colorectal cancer in patients with inflammatory bowel disease over 30 years. Gastroenterology 2012;143:375-81.e1; quiz e13-4
50. WHO. Haemoglobin concentrations for the diagosis of anaemia and assessment of severity. Geneva: World Health Organization; 2011
51. Van Assche G, Dignass A, Panes J, et al.; European Crohn's and Colitis Organisation (ECCO). The second European evidence-based consensus on the diagnosis and management of Crohn's disease: definitions and diagnosis. J Crohns Colitis 2010;4:7-27
52. Dignass A, Eliakim R, Magro F, et al. Second European evidence-based consensus on the diagnosis and management of ulcerative colitis part 1: definitions and diagnosis. J Crohns Colitis 2012;6:965-90
53. EuroQol G. EuroQol-a new facility for the measurement of healthrelated quality of life. Health Policy 1990;16:199-208
54. Cheung WY, Garratt AM, Russell IT, Williams JG. The UK IBDQ-a British version of the inflammatory bowel disease questionnaire. Development and validation. J Clin Epidemiol 2000;53:297-306
55. Harvey RF, Bradshaw JM. A simple index of Crohn's-disease activity. Lancet 1980;1:514
56. Walmsley RS, Ayres RC, Pounder RE, Allan RN. A simple clinical colitis activity index. Gut 1998;43:29-32
57. Sangha O, Stucki G, Liang MH, Fossel AH, Katz JN. The self-administered comorbidity questionnaire: a new method to assess comorbidity for clinical and health services research. Arthritis Rheum 2003;49:156-63
58. Kirkham JJ, Gorst S, Altman DG, et al. Core Outcome Set-STAndards for Reporting: The COS-STAR Statement. PLoS Med 2016;13:e1002148
59. U. S. Department of Health. Guidance for industry: patient-reported outcome measures: use in medical product development to support labeling claims: draft guidance. Health Qual Life Outcomes 2006;4:79
60. Williams JG, Alam MF, Alrubaiy L, et al. Infliximab versus ciclosporin for steroid-resistant acute severe ulcerative colitis (CONSTRUCT): a mixed methods, open-label, pragmatic randomised trial. Lancet Gastroenterol Hepatol 2016;1:15-24
61. Irvine EJ, Zhou Q, Thompson AK. The Short Inflammatory Bowel Disease Questionnaire: a quality of life instrument for community physicians managing inflammatory bowel disease. CCRPT Investigators. Canadian Crohn's Relapse Prevention Trial. Am J Gastroenterol 1996;91:1571-8
62. Alrubaiy L, Cheung WY, Dodds P, et al. Development of a short questionnaire to assess the quality of life in Crohn's disease and ulcerative colitis. J Crohns Colitis 2015;9:66-76
63. Spiegel BM, Hays RD, Bolus R, et al. Development of the NIH Patient-Reported Outcomes Measurement Information System (PROMIS) gastrointestinal symptom scales. Am J Gastroenterol 2014;109:1804-14
64. Carlsen B, Glenton C. What about N? A methodological study of samplesize reporting in focus group studies. BMC Med Res Methodol 2011;11:26
65. Halcomb EJ, Gholizadeh L, DiGiacomo M, Phillips J, Davidson PM. Literature review: considerations in undertaking focus group research with culturally and linguistically diverse groups. J Clin Nurs 2007;16:1000-11
66. Long MD, Kappelman MD, Martin CF, et al. Development of an internet-based cohort of patients with inflammatory bowel diseases (CCFA Partners): methodology and initial results. Inflamm Bowel Dis 2012;18:2099-106
67. Kappelman MD, Long MD, Martin C, et al. Evaluation of the patientreported outcomes measurement information system in a large cohort of patients with inflammatory bowel diseases. Clin Gastroenterol Hepatol 2014;12:1315-23.e2
68. Chung AE, Sandler RS, Long MD, et al. Harnessing person-generated health data to accelerate patient-centered outcomes research: the Crohn's and Colitis Foundation of America PCORnet Patient Powered Research Network (CCFA Partners). J Am Med Inform Assoc 2016;23:485-90
69. BAPEN Malnutrition Advisory Group. The 'MUST' Report: Nutritional screening of adults: a multidisciplinary responsibility-Executive Summary. http://www.bapen.org.uk. Accessed August 28, 2016
70. Prinsen CA, Vohra S, Rose MR, et al. Core Outcome Measures in Effectiveness Trials (COMET) initiative: protocol for an international Delphi study to achieve consensus on how to select outcome measurement instruments for outcomes included in a 'core outcome set'. Trials 2014;15:247